Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity

被引：99
|
作者：
Wyndaele, JJ
Van Dromme, SA
机构：
[1] Univ Antwerp Hosp, Edegem, Belgium
[2] Brugman Hosp, Ctr Traumatol & Revalidat, Brussels, Belgium
来源：
SPINAL CORD | 2002年 / 40卷 / 11期
关键词：
bladder; neurogenic; botulinum toxin; spinal cord injuries;
D O I：
10.1038/sj.sc.3101318
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：599 / 600
页数：2
相关论文
共 50 条
  • [31] Therapeutic effects of detrusor botulinum toxin A injection on neurogenic detrusor overactivity in patients with different levels of spinal cord injury and types of detrusor sphincter dyssynergia
    C-Y Chen
    C-H Liao
    H-C Kuo
    Spinal Cord, 2011, 49 : 659 - 664
  • [32] Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis
    Wu, Shang-Jun
    Xu, Yu-Qiong
    Gao, Zheng-Yan
    Wang, Zhi-Peng
    Zhao, Feng
    Liu, Lin
    Wang, Sheng
    RENAL FAILURE, 2019, 41 (01) : 937 - 945
  • [33] Solifenacin Treatment After Intradetrusor Injections With Botulinum Toxin in Patients With Neurogenic Detrusor Overactivity
    Ciofu, Irina
    Ceausu, Iuliana
    Chirca, Narcis Marian
    Persu, Cristian
    AMERICAN JOURNAL OF THERAPEUTICS, 2022, 29 (05) : E507 - E511
  • [34] Impact of the suspension of neurogenic detrusor overactivity treatment with botulinum toxin due to the COVID-19 pandemic
    Ferreira, Eduardo Freitas
    Silva, Rui
    Ferreira, Anabela
    Carvalho, Maria Paz
    Vale, Paulo
    Faria, Filipa
    UROLOGIA JOURNAL, 2023, 90 (02) : 387 - 394
  • [35] Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: A prospective randomized study
    Giannantoni, A
    Di Stasi, SM
    Stephen, RL
    Bini, V
    Costantini, E
    Porena, M
    JOURNAL OF UROLOGY, 2004, 172 (01) : 240 - 243
  • [36] Concomitant Botulinum Toxin Injections for Neurogenic Detrusor Overactivity and Spasticity-A Retrospective Analysis of Practice and Safety
    Leilaz, Arnaud
    Joussain, Charles
    Denys, Pierre
    Bensmail, Djamel
    Levy, Jonathan
    TOXINS, 2024, 16 (06)
  • [37] Risk of urinary tract infection after detrusor botulinum toxin A injections for refractory neurogenic detrusor overactivity in patients with no antibiotic treatment
    Mouttalib, Sofia
    Khan, Shahid
    Castel-Lacanal, Evelyne
    Guillotreau, Julien
    De Boissezon, Xavier
    Malavaud, Bernard
    Marque, Philippe
    Rischmann, Pascal
    Game, Xavier
    BJU INTERNATIONAL, 2010, 106 (11) : 1677 - 1680
  • [38] Criteria and best clinical practice guidelines for first intradetrusor injection of botulinum toxin type A to treat neurogenic detrusor overactivity
    Perrouin-Verbe, B.
    Ruffion, A.
    Game, X.
    Denys, P.
    Kerdraon, J.
    Karsenty, G.
    de Seze, M.
    Haab, F.
    Saussine, C.
    Soler, J. -M.
    Amarenco, G.
    Chartier-Kastler, E.
    PROGRES EN UROLOGIE, 2009, 19 (06): : 372 - 382
  • [39] Five-year cost analysis of intra-detrusor injection of botulinum toxin type A and augmentation cystoplasty for refractory neurogenic detrusor overactivity
    Padmanabhan, Priya
    Scarpero, Harriette M.
    Milam, Douglas F.
    Dmochowski, Roger R.
    Penson, David F.
    WORLD JOURNAL OF UROLOGY, 2011, 29 (01) : 51 - 57
  • [40] Subjective patient satisfaction after injection of botulinum-A toxin in detrusor overactivity
    Schulte-Baukloh, H
    Weiss, C
    Schobert, J
    Stolze, T
    Stürzebecher, B
    Knispel, HH
    AKTUELLE UROLOGIE, 2005, 36 (03) : 230 - 233
12345